Dietrich Stephan, Ph.D.Chairman and CEO at NeuBase Therapeutics, Inc.
Dr. Stephan is an industry veteran having had a career in academia and in industry. Stephan served as Deputy Director for Discovery Research and chair of the neurogenomics division at TGen, and served as professor and chairman of the Department of Human Genetics at the University of Pittsburgh/UPMC. He has had academic affiliations with Harvard Medical School, Johns Hopkins University, University of Arizona, and Children's National Medical Center. Stephan has identified the molecular basis of dozens of rare and common diseases. Stephan has founded or co-founded 14 biotechnology companies with a focus on molecular diagnostics and first-in-class therapeutics. Stephan co-founded Navigenics (DTC-genomics), was founding Chairman of Pendulum (microbiome therapies), was an early advisor to Guardant Health (liquid biopsy), is founding chairman of Peptilogics (deep learning to mske peptide therapies), and others. Stephan received his Ph.D. from the University of Pittsburgh and his B.S. from Carnegie Mellon University.